This month’s cover story, entitled “Dubious Treatments, ‘Snake Oil Salesmen’ Grab Attention in Rheumatology,” features a ...

Unites Pharma Marketing, PR & Communications, New Product Planning & Commercialization, and Medical Affairs Communities; ...

Fueled by a sustained boom in sales of its diabetes and obesity products, Eli Lilly will become the world’s top-seller of prescription drugs by 2030 and will hold the top rung by a wide margin. | ...

Discover why Genmab A/S stands out as a high-margin biotech with strong partnerships, robust growth prospects, and ...

J&J JNJ announced that the EMA’s Committee for Medicinal Products for Human Use (“CHMP”) recommended granting label expansion ...

The Glioblastoma Treatment Drugs Market is projected to generate USD 844.8 million in revenues by 2025 and is expected to ...

The global aesthetic medical device market is expected to grow significantly, with an estimated market size of USD 14.17 ...

A continuing workforce shortage nationwide has gripped health care as physicians retire, or burn out, and too few new doctors are coming out of medical school to keep up with anticipated growing ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today positive phase I/II data on NXT007 in people with haemophilia A, supporting its progression into phase III clinical development. NXT007 is a ...

Even though the Central government had revised the Uniform Code for Pharmaceutical Marketing Practices (UCPMP) for the pharma industry last year, it remains toothless and statutorily unbinding, ...

The Global Monoclonal Antibody Therapeutics Market is valued at approximately USD 205.09 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 15.0% over the forecast ...